LifeVantage Spokesperson Donny Osmond Appears on Dr Phil Show
SALT LAKE CITY, Feb 9, 2012 -- LifeVantage Corporation, maker of Protandim(R), the Nrf2 Synergizer(TM) patented Dietary Supplement, announced today that its spokesperson, Donny Osmond, appeared on the Dr. Phil show February 8 and shared one of his "secrets" to his youthful appearance and vitality--Protandim. On the heels of Donny's appearance, Protandim ranked first among Google searches in the United States February 8, and remains in the top among Google searches in the United States February 9. In addition to its Google trend ranking, LifeVantage.com visits were up nearly 300% and Protandim.com visits were up over 800% during the same time period.
Donny Osmond, the 2009 "Dancing with the Stars" champion, said he had discovered what he called his own "fountain of youth"--Protandim--during his appearance on the Dr. Phil show. Donny added that he has taken Protandim for two years at his doctor's recommendation and has experienced many health benefits and anti-aging results.
"This continues to be an exciting time for Protandim and LifeVantage," said LifeVantage President and CEO, Douglas C. Robinson. "There is an ever increasing number of Nrf2 studies in many of the most respected universities and institutions around the world. It is also gratifying to know that Protandim is of such interest that people have been typing 'Protandim' in Google searches more than any other word recently."
About Protandim, the Nrf2 Synergizer
Protandim(R) is a clinically demonstrated supplement that provides substantial benefits for healthy aging. Nrf2 is a protein messenger contained in every cell of the body. When activated, Nrf2 enters the cell nucleus and turns on hundreds of survival genes, defensive, stress responsive, cytoprotective genes that enable cells to survive in the face of several different kinds of stress, particularly oxidative stress. This patented Nrf2-activating therapy works in a very different way than conventional antioxidant supplements. Unlike vitamin or carotenoid-containing products that have proven to be largely ineffective in reducing oxidative stress caused by free radicals, Protandim is an indirect antioxidant therapy, which stimulates the body's production of its own powerful antioxidant enzymes and other stress-related gene products. Protandim works at the cellular level, triggering cells to naturally increase production of protective antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione synthase, while decreasing production of pro-inflammatory signals. A peer-reviewed human clinical study showed that after Protandim was taken for 30 consecutive days, important biochemical markers of aging were decreased by an average of 40%. The study also reported that these markers of aging were reduced in the subjects taking Protandim to the level of a typical 20 year old. Protandim is currently the subject of several scientific studies at universities and research facilities. The nature and stages of the studies vary. Under the Dietary Supplement Health and Education Act, Protandim is considered a "dietary supplement". Protandim is not intended for the prevention, diagnosis, treatment, mitigation or cure of any disease.
More LifeVantage News and Articles
- LifeVantage Appoints Charles J Wach COO
- LifeVantage Announces Protandim NRF1 Product Cyber Launch
- LifeVantage Launches PhysIQ Weight Management System
- LifeVantage Launches TrueScience Micro Lift Serum
- LifeVantage Launches Sports Science Lab With Real Salt Lake
- LifeVantage Appoints New CEO
- LifeVantage Launches Operations in Thailand
- LifeVantage Hosts Business Building Event for Women
- LifeVantage Announces Executive Management Change
- LifeVantage Named One of 100 Fastest Growing Companies in Utah
- LifeVantage Launches New Skin Care LIne
- LifeVantage Acquires New Product Line From Wicked Fast Sports Nutrition
- LifeVantage Recognized as Second Fastest Growing Company in Utah
- LifeVantage Awards 55 Jeeps to Top Distributors
- LifeVantage Expands International Operations in Canada
- LifeVantage Announces 3rd Quarter Fiscal 2013 Results
- LifeVantage Canine Health Earns Quality Seal from NASC
- LifeVantage Introduces Canine Health Product
- LifeVantage to Present at the Sidoti Semi-Annual Micro-Cap Conference
- LifeVantage Announces Shares Repurchase Program
- LifeVantage Corporation Announces Voluntary Recall
- LifeVantage to Present at the Wedbush 2012 California Dreamin Consumer Conference
- LifeVantage Lawsuit Dismissed
- LifeVantage Makes a Donation to the Against Malaria Foundation
- LifeVantage Announces First Quarter Fiscal Year 2013 Results
- LifeVantage Appoints New Chief Science Officer
- LifeVantage Announces Record Fourth Quarter and Full Fiscal Year 2012 Results
- LifeVantage Appoints David Colbert as New Chief Financial Officer
- LifeVantage Donates to Hunger Relief International
- LifeVantage Corporation Expands Management Team
- LifeVantage Announces Record Third Quarter Fiscal Year 2012
- LifeVantage Announces Market Expansion at Record Breaking Convention
- LifeVantage Makes Charitable Donation to Traffic Jam
- LifeVantage Featured in OTC Growth Stock Watch Newsletter
- LifeVantage Announces Record Second Quarter
- LifeVantage Spokesperson Donny Osmond Appears on Dr Phil Show
- LifeVantage to Announce Quarterly Results on February 14
- LifeVantage to Present at ICR XChange Conference
- LifeVantage Announces New Peer Reviewed Study
- LifeVantage Announces Record Fiscal Year
- LifeVantage At Accredited Members Conference
- LifeVantage Small Cap Equity Review
- LifeVantage Announces New President
- LifeVantage Dubs Protandim BSCG Approved
- LifeVantage Press Release
- LifeVantage Searches For New CEO
- LifeVantage CEO Refocuses On Marketing Channel
- LifeVantage Press Release
- LifeVantage Announces Board Expansion
- Mexican government approves LifeVantage Protandim
- LifeVantage Announces First Quarter Revenue
- LifeVantage Announces 4th Quarter 2009 Results
- LifeVantage granted third patent for Protandim
- LifeVantage Trims Operating Costs
- LifeVantage Signs Agreement with Montel Williams
- LifeVantage Makes Record Setting Announcement
- LifeVantage to Present at ROTH Capital Partners
- LifeVantage PR Claims Protandim Results
- LifeVantage Shows Loss for Year
- LiveVantage Announces Protandim Sales Increase
- LifeVantage Appoints Richard Doutre Jones
- LifeVantage Expands Global Marketing Initiatives
- LiveVantage Announces Asia Market Expansion
- LifeVantage Announces 2Q 2007 Financials
- Brown Named CEO of LifeVantage
LifeVantage Profile
Create a Free LifeVantage Rep Listing